About this trial
Bone marrow samples will be collected from patients undergoing hip arthroplasty surgery. Blood and bone marrow samples will be used for metabolic profiling and analysis of relevant CHIP mutations. Combined single-cell transcriptomics and mutation-specific single-cell genotyping (biotin-PCR using mutation-targeted primers followed by sequencing) will subsequently be performed. The gene expression profile of wildtype and mutant hematopoietic stem cells will be compared, performing both broad gene set enrichment analysis and targeted analysis of metabolic pathways.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age 65 years and older
Disqualifiers
known haematological condition (myelodysplasia, leukemia, cancer)
inability to provide written informed consent
Trial population
Patients undergoing hip arthroplasty for hip osteoarthritis or osteoporotic hip fractures.
Trial design
Case-control
Prospective
Treatments tested in this trial
Blood and bone marrow cell collection
Other interventionCollection of blood and bone marrow
Treatment groups
Trial outcomes
Primary outcomes
Gene Set Enrichment Analysis (GSEA) Normalized Enrichment Score (NES)
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Imelda Hospital, Bonheiden
Lead sponsor
Université Catholique de Louvain
Collaborator